Analyst Ratings For Amgen, Inc. (NASDAQ:AMGN)
Today, Cantor Fitzgerald reiterated its Neutral rating on Amgen, Inc. (NASDAQ:AMGN) with a price target of $230.00.
There are 9 Hold Ratings, 9 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Amgen, Inc. (NASDAQ:AMGN) is Buy with a consensus target price of $216.9375 per share, a potential 5.15% upside.
Some recent analyst ratings include
- 9/5/2019-Amgen, Inc. (NASDAQ:AMGN) had its Neutral rating reiterated by Cantor Fitzgerald with a $230.00 price target
- 8/30/2019-Amgen, Inc. (NASDAQ:AMGN) had its Hold rating reiterated by William Blair
- 8/27/2019-Amgen, Inc. (NASDAQ:AMGN) had its Market Perform rating reiterated by Wells Fargo & Co with a $220.00 price target
- On 8/7/2019 R Sanders Williams, Director, sold 425 with an average share price of $183.04 per share and the total transaction amounting to $77,792.00.
- On 7/3/2019 Ronald D Sugar, Director, sold 2,000 with an average share price of $187.58 per share and the total transaction amounting to $375,160.00.
- On 6/5/2019 Ronald D Sugar, Director, sold 2,000 with an average share price of $175.68 per share and the total transaction amounting to $351,360.00.
- On 5/1/2019 Ronald D Sugar, Director, sold 2,000 with an average share price of $175.73 per share and the total transaction amounting to $351,460.00.
- On 4/3/2019 Ronald D Sugar, Director, sold 2,000 with an average share price of $193.18 per share and the total transaction amounting to $386,360.00.
- On 3/6/2019 Ronald D Sugar, Director, sold 2,000 with an average share price of $188.88 per share and the total transaction amounting to $377,760.00.
- On 2/7/2019 Ronald D Sugar, Director, sold 2,000 with an average share price of $190.00 per share and the total transaction amounting to $380,000.00.
Recent Trading Activity for Amgen, Inc. (NASDAQ:AMGN)
Shares of Amgen, Inc. closed the previous trading session at 206.32 up +0.80 0.39% with 203 shares trading hands.
